Merck is Very Much a No Go - werkgeversreview Data Research Scientist bij Merck

1,0
28 feb 2016
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

A few good people remain. Company benefits are average or above, other than tuition reimbursement which now is inadequate to earn a MS.

Minpunten

Very much a dying company. Astonishingly bad esprit de corps, much worse now than when I joined over a decade ago. In the past 3 years, 90% of R&D talent has left the company or transferred to other divisions. Upper management are trying to convert all the remaining R&D and IT tasks into mechanized processes to then outsource them (supposedly saving money). All corporate initiative focuses either on saving money or on promoting Keytruda.

Ontdek andere reviews over Merck

5,0
3 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

End of the year shutdown which includes paid time off

Minpunten

The con for me at the time was that I had to relocate which wasn’t possible

4,0
2 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Minpunten

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle